Raimon Sanmarti

Summary

Country: Spain

Publications

  1. doi request reprint Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy
    José A Gómez-Puerta
    Department of Rheumatology, Hospital Clinic, Barcelona, Spain
    Clin Rheumatol 28:95-7. 2009
  2. doi request reprint Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study
    Raimon Sanmarti
    Arthritis Unit, Rheumatology Service, Hospital Clinic of Barcelona, Barcelona, Spain
    J Rheumatol 39:1929-33. 2012
  3. ncbi request reprint Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting
    R Sanmarti
    Hospital Clinic, Rheumatology, Barcelona, Spain
    Rheumatology (Oxford) 42:1044-9. 2003
  4. pmc Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis
    Raimon Sanmarti
    Rheumatology Service, Hospital Clinic of Barcelona, IDIBAPS, Villarroel 170, 08036 Barcelona, Spain
    Arthritis Res Ther 11:R135. 2009
  5. ncbi request reprint Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids
    R Sanmarti
    Arthritis Unit, Rheumatology Service, IDIBAPS, Hospital Clinic of Barcelona, Villarroel 170, Barcelona 08036, Spain
    Clin Rheumatol 26:1111-8. 2007
  6. doi request reprint [Biomarkers in rheumatoid arthritis]
    Raimon Sanmarti
    Unidad de Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, Espana
    Reumatol Clin 6:S25-8. 2011
  7. ncbi request reprint Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial
    R Sanmarti
    Hospital Clinic, IDIBAPS, Rheumatology, Barcelona, Spain
    Rheumatology (Oxford) 44:1140-4. 2005
  8. ncbi request reprint Palindromic rheumatism and other relapsing arthritis
    Raimon Sanmarti
    Arthritis Unit, Rheumatology Service, Hospital Clinic de Barcelona, Villarroel 170, Barcelona 08036, Spain
    Best Pract Res Clin Rheumatol 18:647-61. 2004
  9. ncbi request reprint [Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab]
    Raimon Sanmarti
    Unidad de Artritis, Servicio de Reumatologia, IDIBAPS, Hospital Clinic de Barcelona, Spain
    Med Clin (Barc) 122:321-4. 2004
  10. doi request reprint Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis
    Javier Narvaez
    Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, Barcelona, Spain
    Semin Arthritis Rheum 41:401-5. 2011

Collaborators

Detail Information

Publications45

  1. doi request reprint Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy
    José A Gómez-Puerta
    Department of Rheumatology, Hospital Clinic, Barcelona, Spain
    Clin Rheumatol 28:95-7. 2009
    ..The patient was treated with mycophenolate mofetil (1.5 g/day) with a significant improvement in proteinuria...
  2. doi request reprint Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study
    Raimon Sanmarti
    Arthritis Unit, Rheumatology Service, Hospital Clinic of Barcelona, Barcelona, Spain
    J Rheumatol 39:1929-33. 2012
    ..To analyze longterm progression to rheumatoid arthritis (RA) and the predictive value of anticitrullinated peptide/protein antibodies (ACPA) in palindromic rheumatism (PR)...
  3. ncbi request reprint Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting
    R Sanmarti
    Hospital Clinic, Rheumatology, Barcelona, Spain
    Rheumatology (Oxford) 42:1044-9. 2003
    ..To analyse the frequency and prognostic factors of radiographic progression in a series of Spanish patients with early rheumatoid arthritis (RA) after 1 yr of treatment with disease-modifying anti-rheumatic drugs (DMARDs)...
  4. pmc Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis
    Raimon Sanmarti
    Rheumatology Service, Hospital Clinic of Barcelona, IDIBAPS, Villarroel 170, 08036 Barcelona, Spain
    Arthritis Res Ther 11:R135. 2009
    ....
  5. ncbi request reprint Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids
    R Sanmarti
    Arthritis Unit, Rheumatology Service, IDIBAPS, Hospital Clinic of Barcelona, Villarroel 170, Barcelona 08036, Spain
    Clin Rheumatol 26:1111-8. 2007
    ..The utility of these parameters in clinical practice is limited by their relatively low positive predictive value...
  6. doi request reprint [Biomarkers in rheumatoid arthritis]
    Raimon Sanmarti
    Unidad de Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, Espana
    Reumatol Clin 6:S25-8. 2011
    ..have been studied. The present article reviews research only on soluble biomarkers, mainly those in serum, related to the diagnosis and joint destruction in RA...
  7. ncbi request reprint Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial
    R Sanmarti
    Hospital Clinic, IDIBAPS, Rheumatology, Barcelona, Spain
    Rheumatology (Oxford) 44:1140-4. 2005
    ..To assess the efficacy and safety of adsorptive granulocyte and monocyte apheresis (GCAP) in patients with refractory rheumatoid arthritis (RA)...
  8. ncbi request reprint Palindromic rheumatism and other relapsing arthritis
    Raimon Sanmarti
    Arthritis Unit, Rheumatology Service, Hospital Clinic de Barcelona, Villarroel 170, Barcelona 08036, Spain
    Best Pract Res Clin Rheumatol 18:647-61. 2004
    ..In this chapter, we discuss recent developments in these diseases with special emphasis on palindromic rheumatism, a common condition whose close relationship with rheumatoid arthritis remains intriguing...
  9. ncbi request reprint [Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab]
    Raimon Sanmarti
    Unidad de Artritis, Servicio de Reumatologia, IDIBAPS, Hospital Clinic de Barcelona, Spain
    Med Clin (Barc) 122:321-4. 2004
    ..The aim of this study was to evaluate the efficacy and safety of etanercept in patients with RA, who had previously failed to infliximab...
  10. doi request reprint Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis
    Javier Narvaez
    Department of Rheumatology, Hospital Universitario de Bellvitge IDIBELL, Barcelona, Spain
    Semin Arthritis Rheum 41:401-5. 2011
    ....
  11. ncbi request reprint Macroscopic features of knee synovitis in early untreated Behçet disease and psoriatic arthritis
    Concepción Moll
    Unitat d Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, 08036, Barcelona, Spain
    Clin Rheumatol 28:1053-7. 2009
    ..This exploratory study shows some distinctive features between BD and PsA knee synovitis that confirm macroscopic differences in patients with previously reported immunopathological differences...
  12. ncbi request reprint Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 cases
    Juan D Canete
    Rheumatology Department, Institut Clínic de l Aparell Locomotor ICAL, Hospital Clinic de Barcelona, and Institut d Investigacions Biomédiques Agustí Pí i Suñer IDIBAPS, Universitat de Barcelona, Barcelona, Spain
    Semin Arthritis Rheum 32:378-87. 2003
    ....
  13. doi request reprint Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis
    Virginia Ruiz-Esquide
    Arthritis Unit, Rheumatology Service, IDIBAPS, Hospital Clinic, Barcelona, Spain
    J Rheumatol 38:2536-9. 2011
    ..To analyze the effects of cigarette smoking on disease activity and radiographic damage in patients with early rheumatoid arthritis (RA)...
  14. pmc Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
    Juan D Canete
    Arthritis Unit, Department of Rheumatology, Hospital Clinic de Barcelona and IDIBAPS, Villaroel 170, Barcelona 08036, Spain
    Arthritis Res Ther 11:R17. 2009
    ..The aim of the study was to investigate synovial immunopathology differences between early Behçet disease (BD) and psoriatic arthritis (PsA)...
  15. doi request reprint Synovial fibroblast hyperplasia in rheumatoid arthritis: clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy
    Elena Izquierdo
    Servicio de Reumatologia, Hospital 12 de Octubre, Madrid, Spain
    Arthritis Rheum 63:2575-83. 2011
    ..This study was undertaken to evaluate the fibroblast-specific marker Hsp47 as a quantitative marker for SFs and to analyze its clinicopathologic correlates and evolution after anti-tumor necrosis factor α (anti-TNFα) therapy...
  16. ncbi request reprint Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? A clinical and ultrasonographic study according to anticitrullinated protein antibody status
    Sonia Cabrera-Villalba
    From the Arthritis Unit, Rheumatology Service, Hospital Clinic of Barcelona, Institut d Investigacions Biomèdiques August Pi i Sunyer IDIBAPS Hospital Mútua de Terrassa, Terrassa, Barcelona, Spain Division of Rheumatology, Immunology and Allergy, Section of Clinical Sciences, Brigham and Women s Hospital, Boston, Massachusetts, USA S Cabrera Villalba, MD J Ramirez, MD, Arthritis Unit, Rheumatology Service, Hospital Clinic of Barcelona, IDIBAPS G Salvador, MD, PhD, Hospital Mútua de Terrassa V Ruiz Esquide, MD, PhD M V Hernández, MD, PhD J Inciarte Mundo, MD, Arthritis Unit, Rheumatology Service, Hospital Clinic of Barcelona, IDIBAPS J A Gómez Puerta, MD, PhD, Division of Rheumatology, Immunology and Allergy, Section of Clinical Sciences, Brigham and Women s Hospital J D Cañete, MD, PhD R Sanmarti, MD, PhD, Department of Microbiology
    J Rheumatol 41:1650-5. 2014
    ..To investigate the presence of subclinical synovitis by ultrasound (US) and the clinical phenotype in patients with palindromic rheumatism (PR) according to anticitrullinated protein antibody (ACPA) status...
  17. pmc Ectopic lymphoid neogenesis in psoriatic arthritis
    Juan D Canete
    Servicio de Reumatologia, Hospital 12 de Octubre, 28041 Madrid, Spain
    Ann Rheum Dis 66:720-6. 2007
    ..This process involves the expression of specific homing chemokines and the development of high endothelial venules (HEV)...
  18. ncbi request reprint Association of intermittent hydrarthrosis with MEFV gene mutations
    Juan D Canete
    Hospital Clinic, Barcelona, Spain
    Arthritis Rheum 54:2334-5. 2006
  19. doi request reprint The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis
    Morteza Malakoutikhah
    Department of Biomedical Chemistry, IQAC CSIC, Jordi Girona 18 26, Barcelona, Spain
    J Med Chem 54:7486-92. 2011
    ..Each of the target molecules reported here (fibrin, vimentin, filaggrin) has a specific utility in the identification of a particular subset of RA patients...
  20. pmc Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy
    Elena Izquierdo
    Servicio de Reumatologia, Hospital 12 de Octubre, Madrid, Spain
    PLoS ONE 4:e8131. 2009
    ..We searched for the presence of immature vessels in RA synovium and analyzed the dynamics of synovial vasculature along the course of the disease, particularly after therapeutic response to TNF antagonists...
  21. ncbi request reprint Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature
    Concepción Moll
    Arthritis Unit, Rheumatology Department, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Semin Arthritis Rheum 37:299-306. 2008
    ..We describe 2 new cases with ilium osteitis as the main SAPHO syndrome feature and review reported cases treated with anti-TNF-alpha...
  22. doi request reprint FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-α blockers in psoriatic arthritis: a longitudinal study with 6 months of followup
    Julio Ramirez
    Department of Rheumatology, Arthritis Unit, Hospital Clinic, Barcelona, Spain
    J Rheumatol 39:1035-41. 2012
    ..Our objective was to assess the potential influence of functionally relevant FCGR2A/CD32A (H131R) and FCGR3A/CD16A (V158F) genetic polymorphisms on the EULAR response to tumor necrosis factor-α (TNF-α) blocker therapy in PsA...
  23. doi request reprint Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review
    Laia Gifre
    Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, Spain
    Arch Bronconeumol 47:208-12. 2011
    ..Potential pathogenic mechanisms of the paradoxical effect of anti-TNF treatment is discussed. It is important for clinicians to be aware of this potential and uncommon complication of biological therapy with TNF antagonists...
  24. doi request reprint Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases
    M Victoria Hernández
    Hospital Clinic, Barcelona, Spain
    Arthritis Care Res (Hoboken) 65:2024-31. 2013
    ..To analyze the incidence rate (IR) and risk factors of cutaneous adverse events (CAE) in patients with chronic inflammatory rheumatic diseases treated with tumor necrosis factor (TNF) antagonists...
  25. pmc Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
    Raquel Celis
    Arthritis Unit, Rheumatology Department, Hospital Clinic de Barcelona and IDIBAPS, C Villarroel, 170, 08036 Barcelona, Spain
    Arthritis Res Ther 14:R93. 2012
    ..We determined whether LN is associated with specific patterns of inflammatory cytokine expression in paired synovial tissue (ST) and fluid (SF) samples and their potential correlation with the clinical characteristics of PsA...
  26. doi request reprint Clinical significance of high levels of soluble tumour necrosis factor-α receptor-2 produced by alternative splicing in rheumatoid arthritis: a longitudinal prospective cohort study
    Juan D Canete
    Rheumatology Department, Hospital Clinic of Barcelona, 08036 Barcelona, Spain
    Rheumatology (Oxford) 50:721-8. 2011
    ....
  27. ncbi request reprint An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism
    Juan D Canete
    Institut d Investigacions Biomediques August Pi i Sunyer, and Servei de Reumatologia, Hospital Clinic de Barcelona, Villaroel 170, 08036 Barcelona, Spain
    Arthritis Rheum 56:2784-8. 2007
    ....
  28. ncbi request reprint Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs
    Javier Narvaez
    Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain
    Clin Exp Rheumatol 29:991-7. 2011
    ....
  29. doi request reprint Reduction of biological agent dose in rheumatic diseases: descriptive analysis of 153 patients in clinical practice conditions
    José Inciarte-Mundo
    Unidad de Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, Espana
    Reumatol Clin 10:10-6. 2014
    ..To analyze the frequency and characteristics of dose reduction of biological agents in a cohort of patients with chronic arthritis, in clinical practice conditions in a tertiary level hospital...
  30. doi request reprint Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease?
    Virginia Ruiz-Esquide
    Rheumatology Service, Hospital Clinic, Barcelona, Spain
    Clin Rheumatol 31:1047-50. 2012
    ..The prevalence of ACPA in heavy smokers without RA is low, but seems to be higher in heavy smokers with COPD. Larger studies are necessary to confirm these findings and determine the relationship between ACPA and lung disease...
  31. ncbi request reprint Incidence of full-thickness rotator cuff tear after subacromial corticosteroid injection: A 12-week prospective study
    Julio Ramirez
    Department of Rheumatology, Arthritis Unit, Hospital Clinic, Barcelona, Spain
    Mod Rheumatol 24:667-70. 2014
    ..Corticosteroid injection is highly effective in improving clinical symptoms of rotator cuff tendinopathy at 12 weeks. ..
  32. doi request reprint Abatacept use in rheumatoid arthritis: evidence review and recommendations
    Emilio Martin Mola
    Servicio de Reumatologia, Hospital Universitario La Paz, IdiPAZ, Madrid, Espana
    Reumatol Clin 9:5-17. 2013
    ..To review the clinical evidence on abatacept and to formulate recommendations in order to clear up points related to its use in rheumatology...
  33. doi request reprint Morphea associated with the use of adalimumab: a case report and review of the literature
    Julio Ramirez
    Arthritis Unit, Department of Rheumatology, Hospital Clinic, University of Barcelona, Villarroel 170, Stairway 11, 2nd Floor, 08036, Barcelona, Spain
    Mod Rheumatol 22:602-4. 2012
    ..Adalimumab was discontinued, which resulted in progressive improvement in the skin lesions, with only mild hyperpigmentation remaining. We also review reports of morphea and other adverse cutaneous events related to anti-TNF treatment...
  34. ncbi request reprint Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis
    Juan D Canete
    Institut Clínic de l Aparell Locomotor, and Unitat d Artritis, Servei de Reumatologia, Hospital Clinic de Barcelona, Villaroel 170, 08036 Barcelona, Spain
    Arthritis Rheum 50:1636-41. 2004
    ..Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to analyze the effects of infliximab on angiogenesis in the synovial membrane of patients with PsA who responded to this therapy...
  35. doi request reprint Laryngeal assessment by videolaryngostroboscopy in patients with rheumatoid arthritis
    José A Gómez-Puerta
    Unidad de Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, España División de Reumatología, Brigham and Women s Hospital, Boston, EE UU Electronic address
    Reumatol Clin 10:32-6. 2014
    ..To evaluate the larynx involvement in patients with rheumatoid arthritis (RA) in a clinical setting and correlate with the different clinical features related to more aggressive disease...
  36. ncbi request reprint Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches
    Raimon Sanmarti
    Arthritis Unit, Rheumatology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain
    Curr Top Med Chem 13:698-704. 2013
    ..In this chapter, we present an overview of recent advances in the epidemiology, diagnosis, prognosis and treatment of this severe but treatable disease...
  37. doi request reprint Skin lesions and treatment with tumor necrosis factor alpha antagonists
    Maria Victoria Hernández
    Unidad de Artritis, Hospital Clinic, Universidad de Barcelona, Barcelona, Espana
    Reumatol Clin 9:53-61. 2013
    ..We describe the main skin lesions associated with treatment with anti-TNF drugs according to an extensive review of the literature...
  38. doi request reprint Tobacco and other environmental risk factors in rheumatoid arthritis
    Virginia Ruiz-Esquide
    Unidad de Artritis, Servicio de Reumatologia, Hospital Clinic de Barcelona, Barcelona, Espana
    Reumatol Clin 8:342-50. 2012
    ..In this article we review different environmental factors that have been associated with an increased risk of developing RA, with a special interest in tobacco smoking...
  39. ncbi request reprint Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients
    José Hernández-Rodríguez
    Vasculitis Research Unit, Department of Internal Medicine, Hospital Clinic, University of Barcelona, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
    Medicine (Baltimore) 86:233-41. 2007
    ..Among them, the only patients who appear to be at low risk of developing ischemic events are those in whom a self-limiting episode of cranial symptoms can be recorded...
  40. ncbi request reprint Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis
    María de Gracia Villa
    Instituto de Microelectronica de Barcelona, IMB CNM CSIC, Campus UAB, Bellaterra, Barcelona, Spain
    Biosens Bioelectron 27:113-8. 2011
    ..A comparative study was carried out using control serum from a blood donor, which demonstrated the selectivity of the immunosensor response and its sensitivity for the detection of anti-CFFCP1 antibodies present in RA patients...
  41. doi request reprint [Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ]
    Emilio Martin Mola
    Servicio de Reumatologia, Hospital Universitario La Paz, Madrid, Espana
    Reumatol Clin 7:30-44. 2011
    ..Rituximab has been employed successfully for the treatment of Rheumatoid Arthritis (RA). However, its particular mechanism of action, as well as a lack of concrete guidelines for its management have generated doubts on its use...
  42. ncbi request reprint Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusions
    Alfredo Adan
    Department of Ophthalmology, Hospital Clinic de Barcelona, Universidad de Barcelona, Calle Sabino de Arana, 08036, Barcelona, Spain
    Int Ophthalmol 30:577-81. 2010
    ..Infliximab is an efficient long-term treatment for refractory posterior uveitis. Repeated infusions are required to maintain long-term remission which may be sustained on discontinuation of the drug...
  43. ncbi request reprint Ultrasound evaluation of greater trochanter pain syndrome in patients with spondyloarthritis: are there any specific features?
    Julio Ramirez
    Arthritis Unit, Rheumatology Department, Hospital Clinic, Barcelona, Spain
    Rheumatol Int 34:947-52. 2014
    ..Neither sonography nor MRI was clinically useful in classifying GTPS as a manifestation of SpA...
  44. doi request reprint Model of excellence in Rheumatology Day Hospitals in Spain: the HD-Reumatolex project
    José Andrés Román Ivorra
    Servicio de Reumatologia, Hospital Universitario y Politécnico La Fe, Facultad de Medicina, Universidad Católica de Valencia, Valencia, Espana
    Reumatol Clin 9:142-7. 2013
    ..Few studies have analyzed the situation of Rheumatology Day Hospitals (RDH) in Spain. The HD-Reumatolex project aims to evaluate the situation of Spanish RDHs in terms of strategy, training, management, and quality of care...
  45. ncbi request reprint Successful treatment with infliximab in a patient with Diffuse Subretinal Fibrosis syndrome
    Alfredo Adan
    Department of Ophthalmology, Hospital Clinic de Barcelona, Universidad de Barcelona, Barcelona, Spain
    Am J Ophthalmol 143:533-4. 2007
    ..To report a case of Diffuse Subretinal Fibrosis (DSF) syndrome refractory to immunosuppressive therapy who was successfully treated with anti-tumor necrosis factor-alpha (TNF)-alpha monoclonal antibodies infliximab...